Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Dividend Payout Ratio

: 0.35 (As of Dec. 2023)

View and export this data going back to 1952. Start your Free Trial

Bristol-Myers Squibb Co's dividend payout ratio for the months ended in Dec. 2023 was 0.35.

The historical rank and industry rank for Bristol-Myers Squibb Co's Dividend Payout Ratio or its related term are showing as below:

BMY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.27 Med: 0.38 Max: 0.78
Current: 0.31

During the past 13 years, the highest Dividend Payout Ratio of Bristol-Myers Squibb Co was 0.78. The lowest was 0.27. And the median was 0.38.

BMY's Dividend Payout Ratio is ranked better than
54.57% of 427 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs BMY: 0.31

As of today (2024-04-19), the Dividend Yield % of Bristol-Myers Squibb Co is 4.84%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Bristol-Myers Squibb Co was 4.84%. The lowest was 1.99%. And the median was 2.85%.

Bristol-Myers Squibb Co's Dividends per Share for the months ended in Dec. 2023 was $0.60.

During the past 12 months, Bristol-Myers Squibb Co's average Dividends Per Share Growth Rate was 5.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 8.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 5.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bristol-Myers Squibb Co was 14.20% per year. The lowest was 0.50% per year. And the median was 3.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Bristol-Myers Squibb Co Dividend Payout Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

0.36

0.29

0.27

0.28

0.31

Bristol-Myers Squibb Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Payout Ratio																0.31	0.28	0.33	0.29	0.35

Competitive Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co Dividend Payout Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Dividend Payout Ratio falls into.

Bristol-Myers Squibb Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Bristol-Myers Squibb Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	2.31	/	7.51
	=	0.31

Bristol-Myers Squibb Co's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0.6	/	1.7
	=	0.35

Bristol-Myers Squibb Co (NYSE:BMY) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Bristol-Myers Squibb Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (Bristol-Myers Squibb Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (NYSE:BMY) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Executives

Christopher S. Boerner	officer: EVP, Chief Commercial Officer	21823 30TH DRIVE S, BOTHELL WA 98021
Samuels Theodore R. Ii	director	1990 E. GRAND AVE., EL SEGUNDO CA 90245
Cari Gallman	officer: EVP, Corporate Affairs	BRISTOL MYERS SQUIBB, ROUTE 206 & PROVINCE LINE ROAD, PRINCETON NJ 08543
Ann Powell Judge	officer: SVP, Human Resources	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Robert M Plenge	officer: EVP, Chief Research Officer	C/O TRANSLATE BIO, INC., 29 HARTWELL AVENUE, LEXINGTON MA 02421
Rupert Vessey	officer: Pres., Research & Early Dev.	C/O CELGENE CORPORATION, 86 MORRIS AVENUE, SUMMIT NJ 07901
Adam Lenkowsky	officer: EVP, Chief Commercial Officer	BRISTOL MYERS SQUIBB, ROUTE 206 & PROVINCE LINE ROAD, PRINCETON NJ 08543
Giovanni Caforio	officer: EVP & Chief Commercial Officer	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
David V Elkins	officer: EVP, Chief Financial Officer	C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Deepak Bhatt	director	BRISTOL MYERS SQUIBB, 430 E. 29TH STREET, 14TH FLOOR, NEW YORK NY 10016
Sandra Leung	officer: Vice President and Secretary	C/O BRISTOL MYERS SQUIBB CO, 345 PARK AVE, NEW YORK NY 10164
Sharon Greenlees	officer: SVP & Controller	BRISTOL MYERS SQUIBB, ROUTE 206 & PROVINCE LINE ROAD, PRINCETON NJ 08543
Karin Shanahan	officer: EVP, Glob. Prod. Dev. & Supply	BRISTOL MYERS SQUIBB, ROUTE 206 & PROVINCE LINE ROAD, PRINCETON NJ 08543
Gregory Scott Meyers	officer: EVP, Chief Digital & Tech Off.	BRISTOL MYERS SQUIBB, ROUTE 206 & PROVINCE LINE ROAD, PRINCETON NJ 08543
Autenried Paul Von	officer: SVP, Enterp. Services & CIO	BRISTOL-MYERS SQUIBB COMPANY, 100 NASSAU PARK BOULEVARD, PRINCETON NJ 08543